CHALLENGE ACCEPTED Trademark

Trademark Overview


On Wednesday, July 5, 2017, a trademark application was filed for CHALLENGE ACCEPTED with the United States Patent and Trademark Office. The USPTO has given the CHALLENGE ACCEPTED trademark a serial number of 87516334. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 16, 2024. This trademark is owned by Avista Pharma Solutions, Inc.. The CHALLENGE ACCEPTED trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others

Scientific, technological and testing services, namely, microbiological testing in the pharmaceutical and medical device industries; container closure integrity testing; bacterial filter integrity testing; mycoplasma testing; sterilization validation testing; cleaning validation testing; package validation testing; accelerated aging studies, namely, conducting technical research in the field of product aging; disinfectant qualification programs for clean rooms, namely, developing quality control standards for clean rooms; clean room testing and support services in the nature of monitoring clean room manufacturing practices for quality control operational and design purposes; clean room environmental monitoring services, namely, air surface monitoring, personnel monitoring in the nature of conducting surveys to determine if clean room employees meet employee clean room requirements and standards, temperature and humidity monitoring, pressure differential monitoring, incubation analysis ...
challenge accepted

General Information


Serial Number87516334
Word MarkCHALLENGE ACCEPTED
Filing DateWednesday, July 5, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 16, 2024
Registration Number5395382
Registration DateTuesday, February 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2017

Trademark Statements


Goods and ServicesEarly to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others
Goods and ServicesScientific, technological and testing services, namely, microbiological testing in the pharmaceutical and medical device industries; container closure integrity testing; bacterial filter integrity testing; mycoplasma testing; sterilization validation testing; cleaning validation testing; package validation testing; accelerated aging studies, namely, conducting technical research in the field of product aging; disinfectant qualification programs for clean rooms, namely, developing quality control standards for clean rooms; clean room testing and support services in the nature of monitoring clean room manufacturing practices for quality control operational and design purposes; clean room environmental monitoring services, namely, air surface monitoring, personnel monitoring in the nature of conducting surveys to determine if clean room employees meet employee clean room requirements and standards, temperature and humidity monitoring, pressure differential monitoring, incubation analysis and reporting and isolate characterization and identification; product research and process chemistry services in the pharmaceutical industry; analytical testing and development services for the pharmaceutical industry, namely, structural determination and impurity identification; material characterization, namely, materials testing; evaluation of potential genotoxic impurities in the production of drugs; impurity isolation, namely, chemical laboratory services in the field of impurity isolation for the pharmaceutical industry; analysis of raw materials to specifications; analytical testing to monitor the synthesis and release of drugs; bioanalytical analysis to support discovery and preclinical drug metabolism studies; conducting stability studies of pharmaceutical products; and research and development of drug formulations

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 16, 2024
Primary Code040
First Use Anywhere DateFriday, May 5, 2017
First Use In Commerce DateFriday, May 5, 2017

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 16, 2024
Primary Code042
First Use Anywhere DateFriday, May 5, 2017
First Use In Commerce DateFriday, May 5, 2017

Trademark Owner History


Party NameAvista Pharma Solutions, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameAvista Pharma Solutions, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Party NameAvista Pharma Solutions, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Trademark Events


Event DateEvent Description
Saturday, July 8, 2017NEW APPLICATION ENTERED
Wednesday, July 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 29, 2017ASSIGNED TO EXAMINER
Sunday, October 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 11, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 16, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, December 16, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY